HWI group

With 150 colleagues at 3 sites in Ruelzheim, Frankfurt and Appenweier we look back on 30 years of experience. We offer a service portfolio ranging from product development, analytical development and quality control, manufacturing of clinical batches and smaller market batches to drug safety and GxP services. Together with network partners, HWI also supports clinical and preclinical studies. Our technology platform for parenteral, nasal and oral applications focuses on the development of innovative and affordable drugs with a special focus on poorly soluble small and large molcules. Our purpose is with novel technologies and innovative services to drive the development...

Referenzstandards,analytik,pharmazeutische dienstleistungen,pharmakovigilance,formulierungsentwicklung,pharma,biotech,gxp service,klinische studien,arzneimittel,hwi group,methodenvalidierung,clinical batches,analytics,analytical development,formulation development,vigilance,arzmeimittelsicherheit,and drug safety

Hwi group operates in the Pharmaceutical manufacturing industry.

Hwi group's revenue is 11m - 100m

Hwi group has 51 - 200 employees.